American Express (AXP) Offering Possible 29.2% Return Over the Next 7 Calendar Days

American Express's most recent trend suggests a bullish bias. One trading opportunity on American Express is a Bull Put Spread using a strike $102.00 short put and a strike $97.00 long put offers a potential 29.2% return on risk over the next 7 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $102.00 by expiration. The full premium credit of $1.13 would be kept by the premium seller. The risk of $3.87 would be incurred if the stock dropped below the $97.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for American Express is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for American Express is bullish.

The RSI indicator is at 71.36 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

---

LATEST NEWS for American Express

Rocket Stock Gets Its First Downgrade. Why an Analyst Says to Sell.
Wed, 09 Sep 2020 11:49:00 +0000
Susquehanna analyst downgraded Rocket (ticker: RKT) to Negative, the equivalent of Sell, from Neutral on Monday, while raising his price target to $20 from $18, below Rocket stock’s recent price of $23. Rocket ultimately priced 100 million shares at $18, which was less than the 150 million shares it had initially hoped to price within the $20-$22 range.

RESAAS and Collection Sites Launch COVID-19 Testing Subscription for Real Estate Agents in Las Vegas, NV
Wed, 09 Sep 2020 11:30:00 +0000
Convenient and accessible testing in an attempt to help restore the real estate business responsibly and rapidlyNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce that its wholly owned subsidiary, Collection Sites, LLC has launched its previously announced program (see press release dated August 26, 2020) with RESAAS USA Inc. (TSX-V: RSS) to provide access to a COVID-19 testing initiative for RESAAS’ network of real estate agents and their clients in the State of Nevada. With a captive audience measuring almost 500,000 real estate professionals across the United States, RESAAS and Collection Sites kicks off their campaign focused on mobilizing orders for test kits at an average cost of $60USD per kit.RESAAS will kick off their campaign in Las Vegas, Nevada (USA), utilizing existing Collection Sites operations. Greater Las Vegas has over 15,000 licensed real estate agents, that serve an estimated 3.6 million customers.The initiative enables RESAAS agents and their clients to get tested weekly at Collection Sites testing locations after convenient online purchase. Tests are facilitated by Alcala Laboratory Services, LLC, a CLIA-licensed laboratory based in San Diego, CA.  Under the terms of the arrangement, RESAAS will receive a fee for each test sold by Collection Sites through the RESAAS network of realtors. The launch will continue in conjunction with the planned expansion of Collection Sites locations across the United States.“We are working in symphony with some of America’s leading real estate brands to bring safe and convenient testing to the real estate industry. This is vital for agents to continue doing business through the pandemic,” says Mr. Tom Rossiter, CEO of RESAAS.Timing couldn’t be better.  According to the John Hopkins University of Medicine and their Coronavirus resource center, there are now over 6,296,629 confirmed cases in the United States, with over 189,114 deaths to date.“This pandemic has affected all people, across all professions and industries. Real estate is not unscathed,” says Mr. Rossiter. “The core business of real estate transactions must be restored as there are countless peripheral businesses and industry impacted by the lack of leadership and direction under the circumstances – industries such as finance, property inspectors, home staging, renovation and restoration along with furniture stores, moving companies and other services associated with the buying and selling of residential homes,” says Mr. Rossiter.“We are committed to getting all industries back to providing value, serving customers and doing so within a safer realm of conduct and practice,” stated Mr. Doug Sommerville, the CEO of QuestCap Inc. “The real estate professional marketplace is the perfect industry for our Collection Sites operations given the convenience and accessibility it offers service providers, and the number of interactions the traditional professional will have with clients,” concludes Mr. Sommerville.RESAAS is a global technology platform exclusively for licensed real estate agents, REALTORS®, brokers, franchises and associations. The RESAAS platform is an online marketing channel that generates referrals for agents, acquire leads in real time and promote listings. “We serve almost 500,000 agents worldwide,” says Mr. Rossiter. “RESAAS has a continued commitment to providing the real estate industry new and innovative means to be relevant. We are confident this initiative will provide our customers with renewed levels of confidence to resume the business of buying and selling real estate,” says Mr. Rossiter.About QuestCap Inc. QuestCap Inc. (CSE:QSC; FRA:34C1) is a social-impact investment company. Through QuestCap’s three divisions, MedQuest, TechQuest and ClimateQuest, it seeks, secures and funds recognized sciences, technologies, and solutions that impact our global community today.The QuestCap executive team is complemented by a panel of global advisors that provide expertise across industries and geographies. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopedic treatment, foot and ankle care, and sports medicine.QuestCap’s primary focus is the sale of COVID-19 IgG/IgM antibody tests authorized by FDA under an EUA for use by authorized laboratories. This is achieved largely through two acquisitions: 100% of Nevada-based Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection Sites is setting up a series of QuestCube COVID-19 testing sites across the United States. The pop-up labs will be managed by Collection Sites and powered by Alcala Testing and Analysis Services, a CLIA-licensed laboratory based in San Diego, California. Appointments and payments will be handled through the online portal  www.testbeforeyougo.com. Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution.Other recent MedQuest investments include:  $1M into Sunnybrook Hospital’s Research Group for Emerging and Respiratory Viruses (such amount payable in equal $250,000 installments), $0.5M into Sinai Health Foundation’s research in COVID-19 diagnostic testing (such amount payable in equal $125,000 installments).For additional information, please contact:Doug Sommerville, CEO Doug.Sommerville@questcapinc.comFor investing enquires please contact: Evan Veryard evan.veryard@questcapinc.comFor media enquires please contact: Veronica Welch veronica@vewprmedia.com +1-508-643-8000Cautionary Note Regarding Forward-looking InformationThis press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the launch a COVID-19 testing initiative for real state agents; the pursuit by QuestCap of investment opportunities; and the merits or potential returns of any such investments. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

British Airways Pass Through Trust 2019-1AA — Moody's downgrades British Airways to Ba2 from Ba1; outlook remains negative
Mon, 07 Sep 2020 19:46:06 +0000
Moody's Investors Service, (“Moody's”) has today downgraded British Airways, Plc's (British Airways or the company) corporate family rating to Ba2 from Ba1. Concurrently Moody's has downgraded the ratings of British Airways Pass Through Trust 2019-1AA (Class AA) to A2 from A1, British Airways Pass Through Trust 2019-1A (Class A) to Baa2 from Baa1, British Airways Pass Through Trust 2018-1AA (Class AA) to A2 from A1, British Airways Pass Through Trust 2018-1A (Class A) to Baa2 from Baa1 and Speedbird 2013 Limited transaction (Class A) to Baa2 from Baa1.

Int'l Consolidated Airlines Group, S.A. — Moody's downgrades IAG to Ba2 from Ba1; outlook remains negative
Mon, 07 Sep 2020 19:45:06 +0000
Moody's Investors Service, (“Moody's”) has today downgraded Int'l Consolidated Airlines Group, S.A.'s (IAG or the company) corporate family rating to Ba2 from Ba1 and its probability of default rating to Ba2-PD from Ba1-PD. Concurrently Moody's has downgraded the ratings to B1 from Ba2 of the company's E1 billion senior unsecured notes divided into E500 million series A bonds due 2023 and E500 million series B bonds due 2027.

Dow's nearly 200-point climb led by gains in shares of American Express, JPMorgan Chase
Fri, 04 Sep 2020 13:45:00 +0000
DOW UPDATE The Dow Jones Industrial Average is climbing Friday morning with shares of American Express and JPMorgan Chase seeing positive growth for the index. Shares of American Express (AXP) and JPMorgan Chase (JPM) are contributing to the index's intraday rally, as the Dow (DJIA) was most recently trading 196 points (0.

Related Posts